We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Highly Stable Peptoid Nanosheets May Replace Antibodies in Biosensors

By LabMedica International staff writers
Posted on 13 Nov 2013
Ultra-thin peptoid "nanosheets" constructed from synthetic, peptide-like molecules are able to bind a wide variety of analytes with high specificity and high affinity, which makes them ideal candidates for use as molecular recognition elements for chemical and biological sensors.

In peptoids, the side chain is connected to the nitrogen of the peptide backbone, instead of the alpha-carbon as in peptides. More...
Notably, peptoids lack the amide hydrogen, which is responsible for many of the secondary structure elements in peptides and proteins. Like D-Peptides and beta-peptides peptoids are completely resistant to proteolysis, and are therefore advantageous for applications where proteolysis is a major issue. Since secondary structure in peptoids does not involve hydrogen bonding, it is not typically denatured by solvent, temperature, or chemical denaturants such as urea. As the amino portion of the amino acid results from the use of any amine, thousands of commercially available amines can be used to generate peptoids at costs far lower than would be required for similar peptides.

Investigators at the Lawrence Berkeley National Laboratory (CA, USA) described in the October 2013 issue of the journal ACS Nano the design and synthesis of a new class of functionalized peptoid nanosheets that mimicked antibody binding. The surface of these free-floating nanosheets displayed a high density of conformationally constrained peptide and peptoid loops that generated an extended, multivalent two-dimensional material that was chemically and biologically stable. The nanosheet served as a robust, high-surface area scaffold upon which to display a wide variety of functional loop sequences.

The functionalized nanosheets were characterized by atomic force microscopy, X-ray diffraction, and X-ray reflectivity measurements, and were shown to serve as substrates for enzymes (protease and casein kinase II), as well as templates for the growth of defined inorganic materials (gold metal).

"Antibodies have a really effective architectural design: a structural scaffold that pretty much stays the same, whether it is for snake venom or the common cold, and endlessly variable functional loops that bind foreign invaders," said senior author Dr. Ron Zuckermann, director of the biological nanostructures facility at the Lawrence Berkeley National Laboratory. "We have mimicked that here, with a two-dimensional nanosheet scaffold covered with little functional loops like Velcro."

"The reason that nanosheets form is because there is a code for it programmed directly into the peptoids," said Dr. Zuckermann. "In this case it is admittedly a pretty rudimentary program, but it shows how if you bring in just a little bit of sequence information: Boom! You can make a nanosheet. That is kind of, what my whole research program here is about: learning from the richness of chemical sequence information found in biology to create new types of advanced synthetic materials. We are really just starting to scratch the surface."

Related Links:

Lawrence Berkeley National Laboratory



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.